Spain ups ante on joint procurement of new hepatitis C drugs
This article was originally published in Scrip
Executive Summary
Amid mounting pressure to provide access to the costly new hepatitis C drugs, the Spanish health ministry has confirmed it is pushing for progress on the joint procurement of such products with other EU member states. Companies will be paying close attention to how the situation unfolds as it could set the bar for which treatments come under the scope of a new agreement that allows member states to wield their combined purchasing power to get a better price for expensive new drugs.